Arthroscopic surgery vs sclerosing injection
The review found no eligible studies for this question.
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
Preoperative radiotherapy probably leads to lower overall mortality ( compared with surgery alone (moderate certainty).
Preoperative radiotherapy showed no clear difference in overall mortality ‐ only total mesorectal excision ( compared with surgery alone (low certainty).
Preoperative radiotherapy showed no clear difference in cause‐specific mortality ( compared with surgery alone (low certainty).
Preoperative radiotherapy probably leads to lower local recurrence ( compared with surgery alone (moderate certainty).
Preoperative radiotherapy showed no clear difference in curative resection ( compared with surgery alone (low certainty).
Preoperative radiotherapy showed no clear difference in sphincter preservation ( compared with surgery alone (low certainty).
Preoperative radiotherapy may leads to higher postoperative morbidity ‐ sepsis (within 30 days after surgery) compared with surgery alone (low certainty).
Preoperative radiotherapy may leads to higher postoperative morbidity ‐ surgical complications (within 30 days… compared with surgery alone (low certainty).
It is very uncertain whether methionine and supportive treatment changes mortality compared with supportive treatment (very low certainty).
It is very uncertain whether standard intravenous acetylcysteine regimen (20.5 hour) changes hepatotoxicity compared with shorter intravenous acetylcysteine regimen (12 hour) (very low certainty).
Standard intravenous acetylcysteine regimen (20.5 hour) may leads to lower vomiting, retching, or antiemetics from 0‐2 hours compared with shorter intravenous acetylcysteine regimen (12 hour) (low certainty).
Standard intravenous acetylcysteine regimen (20.5 hour) may leads to lower vomiting, retching, or antiemetics 0‐12 hours compared with shorter intravenous acetylcysteine regimen (12 hour) (low certainty).
Standard intravenous acetylcysteine regimen (20.5 hour) may leads to lower anaphylactoid symptoms compared with shorter intravenous acetylcysteine regimen (12 hour) (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether oral changes nausea compared with intravenous acetylcysteine (very low certainty).
It is very uncertain whether oral changes vomiting compared with intravenous acetylcysteine (very low certainty).
Intravenous acetylcysteine may leads to lower mortality compared with placebo (low certainty).